A detailed history of Clear Street Markets LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Clear Street Markets LLC holds 14,617 shares of CTLT stock, worth $927,887. This represents 0.23% of its overall portfolio holdings.

Number of Shares
14,617
Holding current value
$927,887
% of portfolio
0.23%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$56.16 - $60.96 $820,890 - $891,052
14,617 New
14,617 $885,000
Q2 2023

Aug 14, 2023

BUY
$31.86 - $67.26 $58,654 - $123,825
1,841 Added 523.01%
2,193 $95,000
Q1 2023

May 12, 2023

BUY
$45.44 - $74.26 $7,724 - $12,624
170 Added 93.41%
352 $23,000
Q4 2022

Feb 13, 2023

BUY
$41.39 - $81.0 $7,532 - $14,742
182 New
182 $8,000
Q2 2022

Aug 02, 2022

BUY
$87.2 - $114.05 $26,334 - $34,443
302 Added 408.11%
376 $40,000
Q1 2022

May 11, 2022

BUY
$94.19 - $124.49 $6,970 - $9,212
74 New
74 $8,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Clear Street Markets LLC Portfolio

Follow Clear Street Markets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Street Markets LLC with notifications on news.